【药明生物：2024年度收益同比增长9.6%】金十数据3月25日讯，药明生物(02269.HK)公告，集团截至2024年12月31日止年度的收益同比增长9.6%，达人民币18,675.4百万元，其中非新冠收益同比增长13.1%。毛利同比增长12.1%至人民币7,650.8百万元，纯利同比增长10.5%至人民币3,945.4百万元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.